< /< /P>
(Morning News) Due to the risk of rare thrombosis in vaccination of Johnson & Johnson Coronation, the US Food and Drug Administration (FDA) announced on Thursday (May 5) that it will be limited to those who can vaccinate the mapping vaccine.
Comprehensive foreign news reports, the FDA will be limited to only 18 years old, and those who are not applicable or cannot obtain the vaccination of the inocular messenger ribosaccharides (mRNA) vaccine, and those who do not intend to take over other coronary vaccines can inoculate Johnson & Johnsonvaccine.
A statement issued by the FDA said: "After updating analysis, evaluation and investigation of cases of reports, the FDA confirmed that after about one to two weeks of vaccine vaccines, thrombosis and platelets were low.The risk of TTS (TTS), the risk of the THROMBOSIS with Thrombocytopenia syndrome.> As of March 18, the United States notified 60 TTS cases after vaccine vaccine, including nine cases of death.
However, the official has not completely canceled the authorization of Johnsonal vaccine, and acknowledged that the ban would cause the impact on the global use of the vaccine in the world, and some people may be concerned aboutAdventic virus vectors such as Johnson & Johnson vaccine can be accepted.
According to the US Centers for Disease Control and Prevention (CDC), about 18.7 million people in the United States have vaccinated Johnson & Johnson vaccine, and those who vaccinate the Modner vaccine and Pfizer vaccine are about 217 million and 34,000, respectively.Thousands of people.
